The short answer: both platforms close the door in writing. Google Ads prohibits promoting what it classes as unapproved pharmaceuticals and supplements, and Meta restricts drug and pharmaceutical advertising to certified pharmacies and telehealth providers while banning unsafe substances outright, at its own discretion. Nearly every peptide product on the market falls on the wrong side of one of those lines, which is why peptide companies that try paid acquisition tend to lose the account rather than the auction.
This is worth understanding precisely rather than as folklore, because the exact wording decides what your growth options are. So here is what each policy says, quoted, with links.
What Google Ads policy actually says
Google's healthcare and medicines policy maintains a list of unapproved pharmaceuticals and supplements, and the framing around it is broader than most operators expect. Google says it does not allow the promotion of certain products "regardless of any claims of legality". The prohibited set includes all items on its non-exhaustive list of unapproved pharmaceuticals and supplements, products that imply they are as effective as prescription drugs, and, critically, "products that have been subject to any government or regulatory action or warning".
Read that last clause again, because it does the most work. FDA has sent warning letters to research-peptide sellers, including letters issued in December 2024 over peptide products sold online. Once a product category has drawn that kind of regulatory attention, Google's policy language reaches it even before any individual advertiser gets reviewed. The list is explicitly non-exhaustive, and the policy is written so Google never has to name your product to exclude it.
Two practical consequences follow. First, cleverness does not work: renaming a product, softening the copy, or landing the click on a neutral page are the classic routes to a suspended account, and Google suspensions are difficult to appeal and follow the payment profile, not just the campaign. Second, this is not a temporary state. The policy has been in place for years and the direction of travel is stricter, not looser.
What Meta's advertising standards say
Meta's drugs and pharmaceuticals standard takes a different shape with the same result. Prescription drug promotion is limited to online pharmacies and telehealth providers that are actively certified with LegitScript and have applied to Meta for written permission, and those ads may only run in the United States, Canada and New Zealand, to adults. Everything that is not a certified pharmacy or telehealth operation is outside that gate.
Beneath the certification gate sits a broader clause: ads may not promote illicit or recreational drugs "or other unsafe substances, products or supplements, as determined by Meta at its sole discretion". That discretion clause matters more than the drug language for peptide sellers. Meta does not need your product to be scheduled, or even named anywhere, to remove the ad and restrict the account. Its own judgment is the standard the policy sets.
Could a peptide clinic pursue LegitScript certification? Some telehealth models do. Whether any given clinic qualifies is LegitScript's determination and depends on the products involved and how they are provided, so nobody should promise certifiability, including us. What we can say from the policy text is that certification is the only doorway Meta describes, and product sellers without a pharmacy or telehealth model are not what that doorway is for.
What this means for growth, practically
It means the channel mix for a peptide business is decided before the first marketing dollar is spent. There is no paid search, no paid social, no retargeting pool built from either. What remains is the set of channels that compound rather than rent:
- Organic search, where rankings are earned by the site rather than bought for it
- Branded search, making sure the people who already know you find you rather than a lookalike
- AI-answer presence, being the source that assistants cite when asked about the category
- Email and owned audiences, which no platform policy can repossess
That list is why content quality is not a nicety in this vertical. When organic visibility is the entire acquisition surface, the standard your content has to meet is set by Google's quality systems, and for a category this close to health topics that standard is the highest one Google has. We cover that in the YMYL article in this library.
One caution to close on. None of this is legal advice, and platform policy is not the only rulebook a peptide business answers to. What it is, is the reason the marketing plan for this vertical looks nothing like the plan for an unregulated product, and why the companies that grow are the ones that invested in being findable rather than promotable.
Frequently asked questions
Can peptide companies run Google Ads?
As a practical matter, no. Google's healthcare policy prohibits promoting unapproved pharmaceuticals and supplements regardless of claims of legality, and it extends to products that have been subject to any government or regulatory action or warning. The list Google maintains is explicitly non-exhaustive, so a product does not need to be named on it to be excluded.
Can peptide companies advertise on Meta?
Meta limits prescription drug promotion to online pharmacies and telehealth providers that hold active LegitScript certification and written permission from Meta, in the United States, Canada and New Zealand only. Outside that gate, Meta prohibits ads for unsafe substances, products or supplements as determined at its sole discretion, which is the clause that reaches most peptide marketing.
What happens if a peptide brand tries to run ads anyway?
The common outcome is account suspension rather than a rejected ad. Google suspensions attach to the advertiser and payment profile, not just the campaign, and are difficult to appeal. Attempting workarounds such as renamed products or neutral landing pages is the pattern platforms are best at detecting.
How do peptide companies grow without paid advertising?
Through channels that compound: organic search rankings, branded search protection, presence in AI-generated answers, and owned audiences such as email. Because organic visibility carries the entire acquisition load, content quality and site authority matter more in this vertical than in almost any other.
